Olatorepatide

DRUG2 trials

Sponsors

Regeneron Pharmaceuticals

Conditions

Overweight or Obesity

Phase 2

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US

Active, not recruitingNCT07431086

Regeneron PharmaceuticalsOverweight or Obesity

Start: 2026-03-16End: 2026-12-18Updated: 2026-06-17

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

RecruitingNCT07685808

Regeneron PharmaceuticalsOverweight or Obesity

Start: 2026-07-28End: 2028-01-21Target: 360Updated: 2026-08-20